Tissue Engineering and Regenerative Medicine: Perspectives and Challenges
MedComm · 2025-05 · 6 (5)
DOI: 10.1002/mco2.70192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 24.04.2025. Verfasst von Van T Hoang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vinmec Research Institute of Stem Cell and Gene Technology College of Health Sciences VinUniversity Vinhomes Ocean Park Hanoi Vietnam. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 550 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
From the pioneering days of cell therapy to the achievement of bioprinting organs, tissue engineering, and regenerative medicine have seen tremendous technological advancements, offering solutions for restoring damaged tissues and organs. However, only a few products and technologies have received United States Food and Drug Administration approval. This review highlights significant progress in cell therapy, extracellular vesicle‐based therapy, and tissue engineering. Hematopoietic stem cell transplantation is a powerful tool for treating many diseases, especially hematological malignancies. Mesenchymal stem cells have been extensively studied. The discovery of induced pluripotent stem cells has revolutionized disease modeling and regenerative applications, paving the way for personalized medicine. Gene therapy represents an innovative approach to the treatment of genetic disorders. Additionally, extracellular vesicle‐based therapies have emerged as rising stars, offering promising solutions in diagnostics, cell‐free therapeutics, drug delivery, and targeted therapy. Advances in tissue engineering enable complex tissue constructs, further transforming the field. Despite these advancements, many technical, ethical, and regulatory challenges remain. This review addresses the current bottlenecks, emphasizing novel technologies and interdisciplinary research to overcome these hurdles. Standardizing practices and conducting clinical trials will balance innovation and regulation, improving patient outcomes and quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vinmec Research Institute of Stem Cell and Gene Technology College of Health Sciences VinUniversity Vinhomes Ocean Park Hanoi Vietnam.
- Vinmec Health Care System Hanoi Vietnam.
- School of Chemical Engineering College of Engineering Sungkyunkwan University (SKKU) Suwon Republic of Korea.
ORCID-Profile: Van T Hoang, Nhung Thi Hong Dinh
Zitieren
APA
Hoang, V. T., Nguyen, Q. T., Phan, T. T. K., Pham, T. H., Dinh, N. T. H., Anh, L. P. H., Dao, L. T. M., Bui, V. D., Dao, H. N., Le, D. S., Ngo, A. T. L., Le, Q. D., & Nguyen Thanh, L. (2025). Tissue Engineering and Regenerative Medicine: Perspectives and Challenges. MedComm, 6(5). https://doi.org/10.1002/mco2.70192
Vancouver
Hoang VT, Nguyen QT, Phan TTK, Pham TH, Dinh NTH, Anh LPH, et al. Tissue Engineering and Regenerative Medicine: Perspectives and Challenges. MedComm. 2025;6(5). doi:10.1002/mco2.70192
BibTeX
@article{Hoang2025,
author = {Hoang, Van T and Nguyen, Quyen Thi and Phan, Trang Thi Kieu and Pham, Trang H and Dinh, Nhung Thi Hong and Anh, Le Phuong Hoang and Dao, Lan Thi Mai and Bui, Van Dat and Dao, Hong-Nhung and Le, Duc Son and Ngo, Anh Thi Lan and Le, Quang-Duong and Nguyen Thanh, Liem},
title = {Tissue Engineering and Regenerative Medicine: Perspectives and Challenges},
journal = {MedComm},
year = {2025},
volume = {6},
number = {5},
doi = {10.1002/mco2.70192}
}
EUVIMED